Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
23847studies shown
Showing 8,665-8,676 of 23,847
Drug study icon
CompletedNCT00250575

Safety and Efficacy of Clozapine for schizophrenia

This study is completed in Japan. It is testing safety and Efficacy of Clozapine for schizophrenia.

Multiple locations, including Chiba
SchizophreniaDrugA study involving a medication or substance.From 18 Years to 64 Years
Countries
Japan
Sponsor
Novartis
Condition
Schizophrenia
Drug study icon
CompletedNCT01998958

Safety and Efficacy of Intranasal Esketamine for treatment-resistant depression

This study is completed in the United States, in Belgium, and in Japan. It is testing safety and Efficacy of Intranasal Esketamine for treatment-resistant depression.

Multiple locations, including Birmingham
DepressionDrugFrom 20 Years to 64 Years
Countries
United States, Belgium, Japan
Sponsor
Janssen Research & Development, LLC
Condition
Depression
Drug study icon
CompletedNCT01050582

Safety study of safety and the Effects of Risperidone Compared With Other Atypical Antipsychotic Drugs on the Growth and Sexual Maturation in Schizophrenia

This study is completed in the United States, in Belgium, in Germany, .... It is testing safety and the Effects of Risperidone Compared With Other Atypical Antipsychotic Drugs on the Growth and Sexual Maturation for Schizophrenia.

Multiple locations, including San Francisco
Schizophrenia, BipolarityDrugFrom 8 Years to 16 Years
Countries
United States, Belgium, Germany, ...
Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Condition
Schizophrenia, Bipolarity
Device study icon
CompletedNCT01290991

Safety of Augment™ Bone Graft

This study is completed in Canada. It focuses on OCD.

In Halifax
OCDDeviceA study involving a tool, app, wearable, test, or medical device.From 18 Years to 40 Years
Countries
Canada
Sponsor
Nova Scotia Health Authority
Condition
OCD
Drug study icon
CompletedNCT06107803

Safety study of Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of Co-Administration of Roluperidone and Olanzapine in schizophrenia

This study is completed in the United States. It is testing Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of Co-Administration of Roluperidone and Olanzapine for schizophrenia.

Multiple locations, including Garden Grove
SchizophreniaDrugFrom 18 Years to 55 Years
Countries
United States
Sponsor
Minerva Neurosciences
Condition
Schizophrenia
Drug study icon
CompletedNCT00294008

Treatment Adherence for schizophrenia

This study is completed. It is testing treatment Adherence for schizophrenia.

Location not clearly listed
SchizophreniaDrugOver 18 Years
Countries
Sponsor
Janssen Korea, Ltd., Korea
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.